Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection

Sexually Transmitted Diseases

Volumn 32, Issue 6, 2005, Pages 351-357

  Sexton, Joseph ^a   Garnett, Geoff ^b   Røttingen, John Arne ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Norwegian Health Services Research Centre   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; CLINICAL TRIAL; EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LONGITUDINAL STUDY; MEDLINE; META ANALYSIS; METHODOLOGY; POPULATION RESEARCH; REGRESSION ANALYSIS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; VIRUS TRANSMISSION;

BIAS (EPIDEMIOLOGY); DISEASE TRANSMISSION, HORIZONTAL; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; REGRESSION ANALYSIS; SEXUALLY TRANSMITTED DISEASES;

EID: 19444371537     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000154504.54686.d1     Document Type: Review

References (44)

1. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized controlled trial. Lancet 1995; 346:530-536.
2. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
3. Røttingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiological interactions between classic sexually transmitted diseases and HIV: How much is really known? Sex Transm Dis 2001; 28:579-597.
4. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002; 185:45-52.
5. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care. Williston, VT: BMJ Books, 2001.
6. Stram DO. Meta-analysis of published data using a linear mixed-effects model. Biometrics 1996; 52:536-544.
7. Diggle PJ, Liang K-Y, Zeger SL. Analysis of Longitudinal Data. New York: Oxford University Press, 1994.
8. R [computer program], version 1.8.1. http://www.R-project.org
9. Ploudre PJ, Pepin J, Agoki E, et al. Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. J Infect Dis 1994; 170:313-317.
10. Chirgwin KD, Feldman J, Dehovitz JA, et al. Incidence and risk factors for heterosexually acquired HIV in an inner-city cohort of women: Temporal association with pregnancy. J Acquir Immun Defic Syndr Hum Retrovirol 1999; 20:295-299.
11. Suligoi B, Giuliani M, Galai N, et al. HIV incidence among repeat HIV testers with sexually transmitted diseases in Italy. AIDS 1999; 13:845-850.
12. Martin HL Jr, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-1868.
13. Deschamps MM, Pape JW, Hafner A, et al. Heterosexual transmission of HIV in Haiti. Ann Intern Med 1996; 125:324-330.
14. De Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994; 331:341-346.
15. Gray RH, Wawer MJ, Sewankambo NK, et al. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases in Rakai, Uganda. AIDS 1999; 13:2113-2123.
16. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female-to-male transmission of human immunodeficiency virus type 1: Risk factors for seroconversion in men. Lancet 1989; 2:403-407.
17. Senkoro KP, Boerma JT, Klokke AH, et al. HIV incidence and HIV-associated mortality in a cohort of factory workers and their spouses in Tanzania, 1991 through 1996. J Acquir Immun Defic Syndr 2000; 23:194-202.
18. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95-102.
19. Weir SS, Feldblum PJ, Roddy RE, et al. Gonorrhoea as a risk factor for HIV acquisition. AIDS 1994; 8:1605-1608.
20. Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997; 278:2085-2089.
21. Rubin D, Schenker N. Multiple imputation in health-care data bases: An overview and some applications. Stat Med 1991; 10:585-598.
22. Stram DO, Lee JW. Variance components testing in the longitudinal mixed-effects models. Biometrics 1994; 50:1171-1177.
23. Nopkesorn T, Mock PA, Mastro TD, et al. HIV-1 subtype E incidence and sexually transmitted diseases in a cohort of military conscripts in northern Thailand. J Acquir Immun Defic Syndr Hum Retrovirol 1998; 18:372-379.
24. Kumwenda NI, Taha TE, Hoover DR, et al. HIV-1 incidence among male workers at a sugar estate in rural Malawi. J Acquir Immun Defic Syndr 2001; 27:202-208.
25. Telzak EE, Chiasson MA, Bevier PJ, et al. HIV-1 seroconversion in patients with and without genital ulcer disease. Ann Intern Med 1993; 119:1181-1186.
26. Otten MW Jr, Zaidi AA, Peterman TA, et al. High rate of HIV seroconversion among patients attending urban sexually transmitted disease clinics. AIDS 1994; 8:549-553.
27. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163:233-239.
28. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344:246-248.
29. Kassler WJ, Zenilman JM, Erickson B, et al. Seroconversion in patients attending sexually transmitted disease clinics. AIDS 1994; 8:351-355.
30. Mehendale SM, Rodrigues JJ, Brookmeyer R, et al. Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics. J Infect Dis 1995; 172:1486-1491.
31. Celentano DD, Nelson KE, Suprasert S, et al. Risk factors for HIV-1 seroconversion among young men in northern Thailand. JAMA 1996; 275:122-127.
32. Nelson KE, Eiumtrakul S, Celentano D, et al. The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand. J Acquir Immun Defic Syndr Hum Retrovirol 1997; 16:293-300.
33. Mbizvo MT, Machekano R, McFarland W, et al. HIV seroincidence and correlates of seroconversion in a cohort of male factory workers in Harare, Zimbabwe. AIDS 1996; 10:895-901.
34. Dominguez K, Ellerbrock TV, Harrington PE, et al. Risk factors for HIV seroconversion among young women in rural community in the south-eastern United States. In: Program and abstracts of the XI International Conference on AIDS; July 7-12, 1996; Vancouver, Canada; Abstract Mo.C. 222.
35. Figueroa JP, Ward E, Morris J, et al. Incidence of HIV and HTLV-1 infection among sexually transmitted disease clinic attenders in Jamaica. J Acquir Immun Defic Syndr Hum Retrovirol 1997; 15:232-237.
36. Kapiga SH, Lyamuya EF, Lwihula GK, et al. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 1998; 12:75-84.
37. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998; 12:1699-1706.
38. Kilmarx PH, Limpakarnjanarat K, Mastro TD, et al. HIV-1 serocon-version in a prospective study of female sex workers in northern Thailand: Continued high incidence among brothel-based women. AIDS 1998; 12:1889-1898.
39. Weinstock H, Sweeney S, Satten GA, et al. HIV seroincidence and risk factors among patients repeatedly tested HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996. J Acquir Immun Defic Syndr Hum Retrovirol 1998; 19:506-512.
40. Rakwar J, Lavreys L, Thompson ML, et al. Cofactors for the acquisition of HIV-1 among heterosexual men: Prospective cohort study of trucking company workers in Kenya. AIDS 1999; 13:607-614.
41. Orroth KK, Gavyole A, Todd J, et al. Syndromic treatment of sexually transmitted diseases reduces the proportion of incident HIV infections attributable to these diseases in rural Tanzania. AIDS 2000; 14:1429-1437.
42. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997; 11:F85-F93.
43. McFarland W, Gwanzura L, Bassett MT, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999; 180:1459-1465.
44. Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513-1521.